Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Shares Issued (2022 - 2025)

Gossamer Bio (GOSS) has 4 years of Shares Issued data on record, last reported at $319000.0 in Q3 2025.

  • For Q3 2025, Shares Issued rose 191.67% year-over-year to $319000.0; the TTM value through Sep 2025 reached $1.3 million, up 397.3%, while the annual FY2024 figure was $629000.0, N/A changed from the prior year.
  • Shares Issued reached $319000.0 in Q3 2025 per GOSS's latest filing, up from $240000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $118.2 million in Q4 2022 and bottomed at -$444000.0 in Q4 2023.
  • Average Shares Issued over 4 years is $9.3 million, with a median of $240000.0 recorded in 2025.
  • The widest YoY moves for Shares Issued: up 241.67% in 2024, down 551.95% in 2024.
  • A 4-year view of Shares Issued shows it stood at $118.2 million in 2022, then crashed by 100.38% to -$444000.0 in 2023, then skyrocketed by 241.67% to $629000.0 in 2024, then crashed by 49.28% to $319000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Issued were $319000.0 in Q3 2025, $240000.0 in Q2 2025, and $132000.0 in Q1 2025.